COLL
NASDAQ · Pharmaceuticals
Collegium Pharmaceutical Inc
$35.36
+0.74 (+2.14%)
Open$35.71
Previous Close$34.62
Day High$35.71
Day Low$34.89
52W High$50.79
52W Low$29.11
Volume—
Avg Volume376.4K
Market Cap1.09B
P/E Ratio14.51
EPS$1.88
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+36.2% upside
Current
$35.36
$35.36
Target
$48.15
$48.15
$33.48
$48.15 avg
$61.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 637.67M | 536.13M | 486.77M |
| Net Income | 51.36M | 38.86M | 68.71M |
| Profit Margin | 8.1% | 7.7% | 14.1% |
| EBITDA | 137.10M | 109.51M | 134.63M |
| Free Cash Flow | — | — | 97.48M |
| Rev Growth | +18.9% | +18.9% | +18.7% |
| Debt/Equity | 2.68 | 2.68 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |